#novartis — Public Fediverse posts

https://www.europesays.com/ch/136055/ Fangda, MoFo steer USD900m Boomray-Novartis licence agreement #BellaWang #biotechnology #china #CrossBorderDataTransfer #FangdaPartners #Healthcare #HenryHe #HuangChao #LifeSciences #MergersAndAcquisitions #MorrisonFoerster #Novartis #Pharmaceuticals #ShermanDeng #Suzhou

https://www.europesays.com/ch/135809/ Failure of Novartis’ Pelacarsen Could Reshape the Lp(a) Race for CRISPR and Ionis #CardiovascularEvents #Citi #ClinicalTesting #CRISPRTherapeutics #horizon #IonisPharmaceuticals #Ionis #Novartis

https://www.europesays.com/ch/135691/ Novartis, BMS halt autoimmune CAR-T trials over adverse events #AdverseEvents #AutoimmuneDisease #biotech #BristolMyersSquibb #CART #Cell&GeneTherapy #FierceBiotechHomepage #Novartis

https://www.europesays.com/ch/135677/ Novartis inks $3.2B subcutaneous delivery deal with Alteogen #Alteogen #biologics #biotech #Deals #DrugDelivery #FierceBiotechHomepage #Novartis #SubcutaneousDrugDelivery

https://www.europesays.com/ch/135665/ Novartis Lp(a) drug fails closely watched ph. 3 trial #AntiSenseOligo #biotech #CardiovascularRisks #ClinicalData #ClinicalTrialResults #FailedTrials #FierceBiotechHomepage #IonisPharmaceuticals #Novartis

https://www.europesays.com/ch/135637/ The Day AI Made Me Rethink What Science Could Do #AdvancedAnalytics #AIInDrugDiscovery #AIDrivenResearch #ArtificialIntelligence #BiomedicalResearch #CareersInScience #ChristianDiehl #ClinicalTrialData #DataScience #Data42 #DigitalHealth #DrugDevelopment #FutureOfMedicine #HealthcareTechnology #Novartis #PharmaceuticalInnovation #ReimaginingMedicine #ResearchAndDevelopment #ScientificInnovation #TranslationalAI

https://www.europesays.com/ch/135583/ Telix beams into Novartis’ territory with $1.6B ITM acquisition #biotech #Deals #FierceBiotechHomepage #ITM #MergersAndAcquisitions #Novartis #radiopharmaceuticals #TelixPharmaceuticals

https://www.europesays.com/ch/135177/ Novartis locks in preclinical RLT under $900M Boomray deal #AsiaPacific #BioWorld #BioWorldAsia #BioWorldScience #BoomrayPharmaceuticalsCoLtd #BRP0X0 #cancer #china #DealsAndM&A #diagnostics #Europe #GastroenteropancreaticNeuroendocrineTumors #Lutathera #Novartis #NovartisAG #Pluvicto #ProstateCancer #RadioligandTherapy #radiopharmaceutical #SolidTumors

https://www.europesays.com/ch/135011/ BoomRay and Novartis Pharma sign $900m deal for radioligand therapy #DealWorth #DevelopmentCapabilities #Novartis #NovartisPharma #RadioligandTherapy #UpfrontPayment